13
Views
6
CrossRef citations to date
0
Altmetric
Research

Patent Update Anti-infectives: Emerging anti-HIV agents and targets

Pages 137-159 | Published online: 29 Feb 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

John R Proudfoot. (1998) Non-nucleoside inhibitors of HIV-1 reverse transcriptase. Expert Opinion on Therapeutic Patents 8:8, pages 971-982.
Read now
TarekS. Mansour, ColleenA. Evans, M. Arshad Siddiqui, Marie Charron, Boulos Zacharie, Nghe Nguyen-Ba, Nola Lee & Brent Korba. (1997) Structure-Activity Relationship of Pyrimidine Heterosubstituted Nucleoside Analogues. Nucleosides and Nucleotides 16:7-9, pages 993-1001.
Read now
R Alan Chrusciel & Karen R Romines. (1997) Recent developments in HIV protease inhibitor research. Expert Opinion on Therapeutic Patents 7:2, pages 111-121.
Read now

Articles from other publishers (3)

Xuyi Yue, Yun-Yun Wu & Feng-Ling Qing. (2007) Synthesis of a series of novel 2′,3′-dideoxy-6′,6′-difluoro-3′-thionucleosides. Tetrahedron 63:7, pages 1560-1567.
Crossref
Youhoon Chong, Giuseppe Gumina & Chung K. Chu. (2000) A divergent synthesis of d - and l -carbocyclic 4′-fluoro-2′,3′-dideoxynucleosides as potential antiviral agents. Tetrahedron: Asymmetry 11:24, pages 4853-4875.
Crossref
George W. Koszalka, Susan M. Daluge & F. Leslie Boyd. 1998. 163 171 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.